Determination and properties of proteohormone receptors in malignant gynecological tumors with special reference to lactogen receptors in human breast cancer.

Proteohormone receptors have been demonstrated in gynecological malignancies, but more sensitive methods for measurement of such receptors are required and should be a matter of intensive research. The clinical response of hormone-dependent tumors to endocrine therapy has not yet been correlated with the occurrence of proteo-hormone receptors in neoplastic tissue from gynecological patients and such studies are required.